化工社化工社 化学情報印刷レポート · 研究参考用
HRID 622335作成日:2026年10月26日
N-(tert-Butyloxycarbonyl)glycine N-hydroxysuccinimide ester → t-Butoxycarbonylglycyl thyroxine methyl ester
https://huagongshe.com/reaction/622335
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | N-(tert-Butyloxycarbonyl)glycine N-hydroxysuccinimide ester | HCID 76926 | — |
| 反応物 | Methyl O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosinate | HCID 13911218 | — |
| 溶媒 | Water | HCID 962 | — |
| 生成物 | t-Butoxycarbonylglycyl thyroxine methyl ester | HCID 18602701 | 82.5% |
反応手順
To the Boc-Gly-OSu solution was added under ice-cooling the thyroxine methyl ester solution. The resulting mixture was allowed to stand to reach room temperature, and then stirred for 1.5 hrs. The reaction liquid was allowed to stand overnight, and to this were added 25 ml. of distilled water and 50 ml. of ethyl acetate for extraction with the ethyl acetate. The extraction with 25 ml. of ethyl acetate was repeated three times. The ethyl acetate extracts were combined and dried over anhydrous magnesium sulfate. The dry extract was concentrated in a rotary evaporator and subjected to gel chromatography using a column filled with Sephadex LH-20 (tradename of Pharmacia Corp.). In this procedure, a mixture of acetone and methanol in a volume ratio of 4:1 was employed as the developing solvent. Under confirmation by TLC, the fractions containing the desired product were collected and concentrated under reduced pressure to obtain a crystalline product. There was obtained 950 mg. (yield 82.5%) of the desired product.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US04771008 |
|---|
| 出典データセット | uspto-grants-1988_09 |
|---|
| ORD ID | ord-7f01f9dda47c4d209030b7b666ca05f3 |
|---|
| 出典メモ | uspto-grants-1988_09 |
|---|